SNDX
Syndax Pharmaceuticals, Inc. · Healthcare
CFO Keith A. Goldan sold $72K of Syndax Pharmaceuticals, Inc.
Sold$71,705
$21.03Price
3,410Shares
−2%Stake
What SNDX did after the filing
- The stock from Tue, Feb 10 open, $21.09
- +14.7%
- S&P 500, same days
- −5.5%
Measured over 30 trading days, to the Mar 25 close.
Traded Mon, Feb 9. Filed Tue, Feb 10, 8:59 AM ET, before the open. Returns use the Feb 10 open and the Mar 25 close. Not investment advice.